10Feb
The LHD/ERISA Advisor: Sixth Circuit Rejects MSPA and ERISA Discrimination Claims
Seeking to control healthcare costs, many group health plans have adopted amendments that lower reimbursement rates for the treatment of end-stage renal disease ("ESRD"), which requires long-term dialysis treatment or a kidney transplant, resulting...
By:
Hinshaw & Culbertson LLP
Related
On February 2, 2021, the Federal Trade Commission (FTC) announced revised thresholds for merger noti...
Read More >
The Occupational Safety and Health Administration (“OSHA”) issued a June 20th news release stating...
Read More >
Bay area business software powerhouse Salesforce is “in advanced talks to buy Slack Technologies,”...
Read More >
Dear Legal Mailbag: I try to be fair in dealing with teacher concerns, big and small. But the lates...
Read More >
Projects around the globe are undeniably suffering impacts caused by the COVID-19 pandemic. Those in...
Read More >
Several COVID-19-related mergers and acquisitions (M&A) complaints have been filed with the Delaware...
Read More >